Aim Immunotech (AIM): Director exercised options on 25K shares

25K

Shares

Traded

Mar 12, 2026

Filed

Mar 16, 2026

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

1. Mar 4, 2026Company filing · Form 8-K · Material agreement, Shareholder rightsSigned an important agreement, and changed the rights of its shareholders (and 2 more items)

What came next

1. Apr 10, 2026Company filing · Form 8-K · Material agreementSigned an important agreement
2. May 7, 2026Company filing · Form 8-K · Material agreement, Unregistered sharesSigned an important agreement, and sold new shares without registering them
3. May 8, 2026Company filing · Form 8-K · Unregistered sharesSold new shares without registering them
4. May 18, 2026Company filing · Form 8-K · Material agreement, ResultsSigned an important agreement, and reported its results (and 2 more items)
5. May 20, 2026Company filing · Form 8-K · Material agreement, Unregistered sharesSigned an important agreement, and sold new shares without registering them (and 1 more item)
6. Jun 9, 2026Company filing · Form 8-K · Bylaws or charterChanged its bylaws, charter or fiscal year
7. Jun 9, 2026Company filing · Form 8-K · Material agreement, Unregistered sharesSigned an important agreement, and sold new shares without registering them (and 1 more item)

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Aim Immunotech

For Aim Immunotech, OQRO holds 11 insider filings (SEC Form 4 or Form 144) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its AIM page.

How this filing works

• SEC Form 4
• Open-market purchase
• Rule 10b5-1 trading plans

Other disclosures at Aim Immunotech

• SEC Form 4Nov 13, 2026
• SEC Form 4Nov 12, 2026
• SEC Form 4Nov 10, 2026
• SEC Form 4Nov 9, 2026
• SEC Form 4Nov 6, 2026
• SEC Form 4Oct 26, 2026

Everything OQRO holds on this company is on its AIM page.